ducovest

ADUS:NGS-Addus HomeCare Corporation (USD)

EQUITY | Medical Care Facilities | Nasdaq Global Select

Last Closing

USD 120.32

Change

-1.63 (-1.34)%

Market Cap

USD 0.39B

Volume

0.11M

Analyst Target

USD 119.88
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Addus HomeCare Corp provides home and community based services, which are social in nature and are provided in the home, focused on the dual eligible population.

Company Website : http://www.addus.com

Currency: USD

Country : USA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-08-02 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap
ENSG The Ensign Group Inc

N/A

 USD 8.66B
ACHC Acadia Healthcare Company Inc

N/A

 USD 7.10B
OPCH Option Care Health Inc

N/A

 USD 5.48B
SGRY Surgery Partners Inc

N/A

 USD 3.93B
AMED Amedisys Inc

N/A

 USD 3.18B
LFST Lifestance Health Group Inc

N/A

 USD 2.41B
ASTH Astrana Health Inc

N/A

 USD 2.17B
AVAH Aveanna Healthcare Holdings In..

N/A

 USD 1.05B
HCSG Healthcare Services Group Inc

N/A

 USD 0.79B
CCRN Cross Country Healthcare Inc

N/A

 USD 0.51B

ETFs Containing ADUS

SBM 7.23 % 0.95 %

N/A

 N/A
SMN ProShares UltraShort Basi.. 7.23 % 0.95 %

N/A

 N/A
JHMA 4.37 % 0.47 %

N/A

 N/A
XLPE:LSE Xtrackers LPX Private Equ.. 3.49 % 0.00 %

N/A

 N/A
SXLB:LSE SPDR S&P U.S. Materials S.. 3.31 % 0.00 %

N/A

 N/A
IMSU:LSE iShares S&P 500 Materials.. 3.29 % 0.00 %

N/A

 N/A
2B7B:XETRA iShares S&P 500 Materials.. 3.28 % 0.00 %

N/A

 USD 0.12B
UYM ProShares Ultra Basic Mat.. 2.41 % 0.95 %

N/A

 N/A
JSML Janus Henderson Small Cap.. 1.80 % 0.50 %

N/A

 USD 0.22B
VVAL:LSE 0.54 % 0.00 %

N/A

 N/A
SCHJ Schwab 1-5 Year Corporate.. 0.09 % 0.00 %

N/A

 N/A
BIV Vanguard Intermediate-Ter.. 0.05 % 0.07 %

N/A

 N/A
BLV Vanguard Long-Term Bond I.. 0.04 % 0.07 %

N/A

 N/A
BSV Vanguard Short-Term Bond .. 0.02 % 0.07 %

N/A

 N/A
SPVM Invesco S&P 500 Value wit.. 0.00 % 0.39 %

N/A

 USD 0.09B
WMCR 0.00 % 0.50 %

N/A

 N/A
SCHI Schwab 5-10 Year Corporat.. 0.00 % 0.00 %

N/A

 USD 7.40B

Market Performance

  Market Performance vs. Industry/Classification (Medical Care Facilities) Market Performance vs. Exchange (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 29.59% 85% B 88% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 29.59% 85% B 88% B+
Trailing 12 Months  
Capital Gain 28.25% 88% B+ 86% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 28.25% 88% B+ 85% B
Trailing 5 Years  
Capital Gain 50.87% 50% F 74% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 50.87% 50% F 71% C-
Average Annual (5 Year Horizon)  
Capital Gain 4.77% 58% F 59% D-
Dividend Return 4.77% 58% F 55% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 20.87% 96% N/A 75% C
Risk Adjusted Return 22.85% 67% D+ 57% F
Market Capitalization 0.39B 73% C 80% B-

Key Financial Ratios

  Ratio vs. Industry/Classification (Medical Care Facilities) Ratio vs. Market (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 49.30 60% 32%
Price/Book Ratio 3.04 29% 33%
Price / Cash Flow Ratio 19.40 27% 16%
Price/Free Cash Flow Ratio 20.36 27% 13%
Management Effectiveness  
Return on Equity 9.56% 83% 76%
Return on Invested Capital 9.78% 78% 78%
Return on Assets 6.56% 96% 90%
Debt to Equity Ratio 17.57% 58% 63%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.